Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 33 M34.7 M36.09 M35.99 M35.91 M41.91 M 149.91 M Research & development —————— — Operating income 19.89 M17.24 M18.88 M13.81 M3.57 M2.9 M 39.16 M Non-Operating Income, Total -517 K116 K-1.39 M1.42 M97 K-4.29 M -4.16 M Interest expense, net of interest capitalized 666 K772 K898 K858 K848 K640 K 3.24 M Non-Operating Income, excl. Interest Expenses -666 K-772 K-898 K-858 K-848 K-640 K -3.24 M Unusual income/expense -517 K116 K-1.39 M1.42 M97 K-4.29 M -4.16 M Pretax income 19.57 M17.18 M17.24 M16.92 M4.32 M1.87 M 40.34 M Equity in earnings 219 K598 K640 K621 K527 K786 K 2.57 M Taxes 857 K744 K1.02 M-130 K253 K100 K 1.24 M Non-controlling/minority interest 16.03 M14.07 M14.09 M13.53 M3.5 M1.52 M 32.64 M After tax other income/expense —————— — Net income before discontinued operations 2.68 M2.37 M2.13 M3.52 M565 K246 K 6.46 M Discontinued operations —————— — Net income 2.68 M2.37 M2.13 M3.52 M565 K246 K 6.46 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 2.72 M2.37 M2.13 M3.72 M565 K246 K 6.66 M Basic earnings per share (Basic EPS) 0.30.260.240.390.060.03 0.72 Diluted earnings per share (Diluted EPS) 0.30.260.240.390.060.03 0.72 Average basic shares outstanding 8.97 M9 M9.02 M9 M9.05 M8.38 M — Diluted shares outstanding 9.13 M9 M9.06 M9.21 M9.05 M8.38 M — EBITDA 20.6 M18.05 M19.83 M14.84 M4.67 M3.98 M 43.31 M EBIT 19.89 M17.24 M18.88 M13.81 M3.57 M2.9 M 39.16 M Cost of revenue 171.19 M171.99 M207.07 M208.7 M165.99 M225.1 M 806.87 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) 709 K813 K944 K1.03 M1.1 M1.08 M 4.15 M